public health – Page 31 – The NEN

Health Emergency: Worst ever four-hour performance “must be a call to action”

“The health service is in the middle of the biggest crisis it has ever faced“

The latest monthly Emergency Department (ED) performance figures published by NHS England for December 2021 show that four-hour performance at major Emergency Departments reached its lowest since records began at 61.2%, meaning nearly two in five patients were delayed by four-hours or more and nearly 1 in 4 admissions experienced a wait of at least four hours from the decision to admit them to admission.

The data also show the highest number of 12 hour waits ever recorded: 12,986 patients spent 12 hours or more from decision to admit to admission. This is a 22% increase on the previous month, November 2021, and it is 250% higher than December 2020.

Responding to the publication of NHS England quarterly and monthly performance figures, Dr Katherine Henderson, President of the Royal College of Emergency Medicine, said: “The situation on the ground is extremely bleak. Staff are overwhelmed and burned out; it is increasingly challenging to provide timely and safe patient care.”

Latest Quarterly performance figures published by NHS England show that in 2021-2022 there were a total of 43,218 12-hour delays which is more than all the 12-hour delays over the previous ten years put together (39,608).

The data does not paint the full picture as NHS England record 12-hour waits from decision to admit. Our Winter Flow project, which started at the beginning of October 2021, has so far recorded 71,965 12-hour waits from time of arrival.

It is critical that NHS England commit to reporting 12-hour data from time of arrival and implement the Clinical Review of Standards.

Dr Henderson said: “The health service is in the middle of the biggest crisis it has ever faced, and staff are working harder than ever before with fewer staff and fewer beds.

“When the health service is overwhelmed, it does not cease to function, it is the standards and quality of care that fall. The figures published today show the extent to which these standards have fallen already.

“Performance metrics are intended to hold clinical services to account. They are meant to identify areas in which services are failing with the aim of improving them quickly and effectively.

“The consistent and continuous decline of urgent and emergency care performance, standards, patient experience and patient safety show how this intended function is now entirely lost. With each publication around performance, we commentate with shock and dismay at the latest decline, but our comments are, more often than not, met with inaction or short-term fixes. There needs to be acknowledgment that there is a major public health crisis in emergency care.

“It is the core ability and function of the health and social care service to deliver high-quality and effective care to the acutely ill or injured that is at risk.

“We must now see a vision for recovery and a vision for the health service that includes a vital transformation of the urgent and emergency care system. There must be a plan to implement a framework that is centred around patient care, that drives action and improvement.

“The current framework is simply documenting the health system’s failure to deliver a quality service, and the failure of this framework leaves urgent and emergency care in a performance vacuum.

“We need a decision about either a phased implementation of the findings of the Clinical Review of Standards or an honest discussion about how we performance manage urgent and emergency care differently.

“The current challenges facing the health and social care service are the result of years of stagnation and decline, they are made worse by, but are not just a consequence of, the pandemic. Recognising this is vital to any step towards transformation.

“It is time we saw bolder political willingness to engage on these critical issues. Without action, performance will continue to decline, and this would be a disservice to patients and staff.”

New blood cancer gene defect can be treated with existing drugs

A defective gene, normally found in blood cancers, could be treated with drugs already available for cancers with similar gene defects, scientists at Queen’s University Belfast and the University of Birmingham have revealed.

The research team, funded mainly by Cancer Research UK and the Medical Research Council, found that tumours with mutations in the SF3B1 gene respond to PARP inhibitors, a type of drug used to treat cancers which have similar mutations in the BRCA1 and BRCA2 genes.

The researchers believe that PARP inhibitors could be used to treat patients with tumours carrying the defective SF3B1 gene. This mutation is most often found in blood cancers, including chronic lymphocytic leukaemia, as well as some rare cancers like uveal melanoma.

Dr Kienan Savage, lead author and Reader at the Patrick G Johnson Centre for Cancer Research at Queen’s, (above) said: “Our findings have clinical implications for the treatment of many cancers.

“We specifically focused on this genetic mutation as it is found in several difficult to treat leukaemias and other cancers, and it affects so many cancer patients. By deepening our understanding of this gene mutation, we have identified new ways of treating these cancers that could improve survival rates.”

PARP inhibitors, which include olaparib and rucaparib, are used to treat some patients with ovarian, breast, prostate and pancreatic cancers – usually patients who have inherited a faulty BRCA1 or BRCA2 gene. Around 1 in 400 people have a faulty BRCA1 or BRCA2 gene.

The research, published today in Cancer Research, a journal of the American Association for Cancer Research, found that the SF3B1 mutation produces similar effects to the faulty BRCA1 gene by damaging DNA, preventing it from being repaired properly, and stopping it from making normal copies of itself. PARP inhibitors target the cell’s DNA repair tools by locking them in place on the DNA. This stops DNA repair, causing the cancer cells to die.

The scientists found that cancer cells with the SF3B1 mutation were sensitive to olaparib, the most common PARP inhibitor, some specific chemotherapies and to radiotherapy. The scientists believe that the SF3B1 mutation disrupts the cell’s ability to make DNA repair proteins, leaving it vulnerable to drugs which target these proteins.

The SF3B1 mutation occurs in up to 30% of blood cancers called myelodysplastic syndromes, where blood cells don’t form properly. They are difficult to treat as they occur predominantly in older patients who may not be considered fit for treatment. The mutation is also common among uveal melanoma or cancers of the eye, which currently have limited treatment options.

Dr Katrina Lappin, from Queen’s and first author of the study, added: “Our research shows that cancers with these specific mutations, may be treated effectively with PARP inhibitor therapy drugs, which are less toxic, better at killing cancer cells with these mutations and can be taken at home in tablet form. This could have huge implications for improving outcomes and quality of life of people with these cancers.”

“This work will pave the way for clinical trials using PARP inhibitors for the treatment of patients with this commonly associated cancer mutation, allowing a more personalised approach to the treatment of these cancers.”

The researchers now want to test PARP inhibitors in clinical trials with patients who have the SF3B1 mutation to see if they can stop their cancer from spreading.

Co-author Professor Grant Stewart, of the University of Birmingham, said: “Our work demonstrates that a molecular understanding of how a specific gene mutation affects a cancer cell’s ability to repair damaged DNA can be exploited clinically to specifically tailor the anti-cancer therapy used to treat an individual’s tumour.

“This will increase the effectiveness of the therapy and hopefully, reduce the chances of re-occurrence.”

Michelle Mitchell, Chief Executive of Cancer Research UK, said: “Our scientists helped to discover the BRCA gene over 25 years ago and since then we’ve led the way in developing PARP inhibitors to treat cancers with BRCA gene faults.

“It’s really exciting to hear about a new mutation, which behaves like the BRCA1 mutation and could in the future be treated in the same way. With PARP inhibitors already widely available, there is huge potential to help people with some of the rarest and most difficult-to-treat cancers known to us.

“Over the past two decades, PARP inhibitors have saved thousands of lives worldwide, and it will be interesting to see if this research in the future could lead to a similar impact for people with rarer cancers.”

The research was funded by the UK Medical Research Council, Cancer Research UK, Blood Cancer UK, Leukaemia and Lymphoma NI and Great Ormond Street Hospital Children’s Charity.

Increasing mental health support in GP practices

Funding to reach £40 million a year

More mental health and wellbeing services will be provided within GP practices and community settings, backed by investment of up to £40 million a year.

Under the new system, patients who need mental health support will find a range of professionals available through their doctor’s surgery, rather than having to rely solely on their GP or a referral elsewhere. These could include mental health nurses, psychologists, peer support workers, occupational therapists, and link workers.

Funding of £1.5 million has already been made available from the Mental Health Recovery and Renewal Fund. This will increase annually to support implementation of the new Mental Health and Wellbeing Primary Care Services, reaching an expected £40 million per year by 2024-25.

This could amount to more than £100 million by the end of this Parliament, substantially increasing the mental health workforce and transforming how support is delivered.

Minister for Mental Wellbeing Kevin Stewart said: “Mental ill health is one of the major public health challenges in Scotland. We know the pandemic has had a significant impact, which is why mental health has remained a priority throughout our response to COVID-19.

“Around a third of all GP consultations now has a mental health component. But the range and complexity of issues requires a more varied and comprehensive response.

“This new multi-disciplinary model will deliver our commitment to provide 1,000 additional dedicated mental health staff by 2026, supporting communities to improve their mental health.”

Deputy chair of BMA Scotland’s GP Committee Dr Andrew Cowie said: “Scotland’s mental health has suffered significantly throughout the COVID19 pandemic, and we welcome the additional mental health staff that will allow for our patients to access support within their communities.

“GP practices are most people’s first point of contact and it is important that there is a range of help and services available there. This is a welcome initiative and we look forward to working with the Scottish Government to develop the scheme and ensure all patients in Scotland can access better mental health in their communities.”

Local Planning Guidance, to support integration authorities and local partners to plan and implement the new services, will be published on the Scottish Government’s website this week.

Services will also link to community support such as addiction services, food banks and benefit support, through a link worker dedicated to each GP practice.

UK Government urges pregnant women to Get Boosted Now

Pregnant women are being urged to Get Boosted Now in a new advertising campaign launched today over social media and radio

Pregnant women are being urged to Get Boosted Now in a New Year advertising drive launched today
New social media and radio assets highlight the risks of catching the virus and benefits of the vaccines to both mothers and their babies
Almost all pregnant women who were hospitalised or admitted to intensive care with COVID-19 were unvaccinated

Pregnant women who have not yet had their first, second, third or booster dose of a COVID-19 vaccine are being urged to get their jab as soon as possible, as the government launches a new advertising campaign for the New Year.

The new campaign joins forces with the experts at the Royal College of Obstetricians and Gynaecologists (RCOG) and the Royal College of Midwives (RCM) to highlight the serious risks of catching COVID-19 and the benefits the vaccines bring to protecting both mothers and their babies.

Testimonies of pregnant women who have had the jab to keep themselves safe will be played out in adverts across social media and radio stations across the country from today [Monday January 10].

The new campaign urges pregnant women ‘don’t wait to take the vaccine’ and highlights the risks of COVID-19 to mother and baby, and the benefits of vaccination.

The latest data from the UK Health Security Agency (UKHSA) shows COVID-19 vaccinations provide strong protection for pregnant women against the virus. It also shows the vaccines are safe for pregnant women, with similar birth outcomes for those who had the vaccine and those who had not.

DHSC Chief Scientific Adviser and Honorary Consultant Obstetrician Professor Lucy Chappell said: “Getting a COVID-19 vaccine is one of the most important things a pregnant woman can do this year to keep herself and her baby as safe from this virus as possible.

We have extensive evidence now to show that the vaccines are safe and that the risks posed by COVID-19 are far greater.

“If you haven’t had your COVID-19 vaccine, I would urge you to speak to your clinician or midwife if you have any questions or concerns, and book in your vaccine as soon as you can.”

Data from the UK Obstetric Surveillance System shows 96.3% of pregnant women admitted to hospital with COVID-19 symptoms between May and October 2021 were unvaccinated, a third of which (33%) requiring respiratory support. Around 1 in 5 women who are hospitalised with the virus need to be delivered preterm to help them recover and 1 in 5 of their babies need care in the neonatal unit.

The COVID-19 vaccines are safe for pregnant women and have no impact on fertility, which has been made extremely clear by the government, its senior clinicians and a range of independent experts from stakeholder groups such as RCOG the Royal College of Midwives (RCM) and the British Fertility Society.

Since April 2021, around 84,000 pregnant women have received one dose and over 80,000 have received two doses of the COVID-19 vaccine. In August 2021, only 22% of women who gave birth were vaccinated.  

Dr Edward Morris, President of the Royal College of Obstetricians and Gynaecologists, said: “We welcome this national campaign as an important way of amplifying the very clear message to pregnant women that vaccination provides the best protection for both them and their babies from COVID-19. We urge all pregnant women to get vaccinated as soon as possible, and to get boosted 3 months after the second dose.

We are very concerned that many pregnant women have not yet been vaccinated against COVID-19 and we hope this campaign will help reassure them that vaccination is safe and effective. Pregnant women are more vulnerable of becoming seriously ill from COVID-19 infection, and this can lead to an increased risk of giving birth prematurely, and stillbirth.

“Gill Walton, Chief Executive and General Secretary of the Royal College of Midwives (RCM), said: There is overwhelming evidence that the COVID vaccine is safe for pregnant women and for their babies – and that it’s the best way to keep them safe from harm. Sadly, there are too many pregnant women being admitted to hospital with COVID, and 96.3% of them haven’t been vaccinated.

“The consequences of COVID when you are pregnant are clear and potentially devastated, from increased possibility of premature birth and admission to intensive care to a heightened risk of stillbirth.

“We know that pregnant women want to do everything they can to protect their baby, which is why midwives want to reassure them that vaccination is the best thing they can do.”

Dr Jen Jardine, from the Royal College of Obstetricians and Gynaecologists, who is also seven months pregnant and has had her COVID-19 booster jab, said: “Both as a doctor and pregnant mother myself, we can now be very confident that the COVID-19 vaccinations provide the best possible protection for you and your unborn child against this virus.

“I would strongly call on all pregnant women like me, if you haven’t had the vaccine yet, to either speak to your GP or midwife if you still have questions and then book right away today.”

Humzah Yousaf: “We believe Omicron has not yet peaked”

‘Vaccination is vital’: Scots urged to get boosted as soon as possible

Anyone who has not yet received their booster or third dose is being urged to come forward now, to give the best possible protection against the Omicron variant.

That includes anyone who was unable to attend a vaccination clinic before the Hogmanay bells because of a COVID-19 infection, or if they were self-isolating.

People who are aged 18 and over can receive a booster 28 days after they tested positive or if it has been at least 12 weeks since their second dose.

Young people aged 12-17 can also attend for their second dose of the vaccine – many will have received an appointment but this group can also attend a drop-in clinic at a time and place convenient for them as long as 12 weeks have passed since their first jab.

Health Secretary Humza Yousaf said: “The recent acceleration of activity in response to the emerging threat of the Omicron variant has been a remarkable national endeavour and I can’t stress enough how grateful we are to all those involved.

“More than three million people have now received a booster or third dose, offering strengthened protection from the virus and reducing the risk of hospitalisation from the virus.

“However, we believe Omicron has not yet peaked, and the pressure being felt by the health and social care system is extremely high. So, to protect ourselves and the NHS at this critical time it is vital people complete the vaccination course for which they are eligible. It remains vital that everyone gets their booster vaccine when they are eligible.

“We know many people have been unable to attend appointments because of the virus, or due to self-isolation, so I urge anyone who has been unable to attend to rearrange it or go to a drop-in clinic.

“It is never too late to receive your booster – or a first or second dose – so please come forward as soon as possible, as there is plenty of capacity available.”

Deputy Chief Medical Officer Nicola Steedman said: “Data shows you are significantly more likely to be admitted to hospital if you are unvaccinated.

“We now know that boosters provide the best possible protection against this variant of the virus. My clinical colleagues and I know the difference this will make – we see it in our hospitals and communities every day. Please get vaccinated.”

Find out more about the COVID-19 vaccination at NHS Inform

No need for second booster at this time, say health experts

Boosters continue to provide high levels of protection against severe disease from Omicron in older adults

Latest data from UKHSA shows booster doses are continuing to provide high levels of protection against severe disease from the Omicron variant among older adults.

Figures show that around 3 months after they received the third jab, protection against hospitalisation among those aged 65 and over remains at about 90%.

With just 2 vaccine doses, protection against severe disease drops to around 70% after 3 months and to 50% after 6 months.

The Joint Committee on Vaccination and Immunisation (JCVI) has taken this latest evidence into account in their ongoing review of the booster programme.

The Committee advises that at this present time:

there is no immediate need to introduce a second booster dose, or fourth jab, to the most vulnerable (care home residents and those aged over 80) – the timing and need for further booster doses will continue to be reviewed as the data evolves
priority should continue to be given to rolling out first booster doses to all age groups
unvaccinated individuals should come forward for their first 2 doses as soon as possible

Professor Wei Shen Lim, the JCVI’s chair of COVID-19 immunisation, said: “The current data shows the booster dose is continuing to provide high levels of protection against severe disease, even for the most vulnerable older age groups.

“For this reason, the committee has concluded there is no immediate need to introduce a second booster dose, though this will continue to be reviewed.

“The data is highly encouraging and emphasises the value of a booster jab. With Omicron continuing to spread widely, I encourage everyone to come forward for their booster dose, or if unvaccinated, for their first 2 doses, to increase their protection against serious illness.”

The latest study looked at booster doses in those aged over 65, who were among the first to be eligible when the booster rollout began in mid-September.

Whilst with a booster dose, the duration of protection against severe disease remains high, protection against mild symptomatic infection is more short-lived and drops to around 30% by about 3 months.

First anniversary of UK deploying Oxford-AstraZeneca vaccine

A year ago today, the UK became the first country in the world to administer the Oxford University/AstraZeneca vaccine
Vaccination programme has been a phenomenal success, saving countless lives and reducing pressure on NHS

One year ago today [Tuesday 4 January 2021] the UK became the first country in the world to administer the Oxford University/AstraZeneca COVID-19 vaccine.

Brian Pinker, 82, (above) was the first person to receive the life-saving vaccine outside of clinical trials at Oxford University Hospital at 7.30am.

Since then, around 50 million AstraZeneca vaccines have been administered in the UK, saving countless lives, keeping people out of hospital and reducing the pressure on the NHS.

To mark the anniversary, the Secretary of State for Health and Social Care, Sajid Javid, will visit a vaccination centre in London to thank hard-working NHS staff and volunteers delivering jabs.

Health and Social Care Secretary Sajid Javid said: “Backed by government funding, the UK-made Oxford-AstraZeneca vaccine has played an absolutely crucial role in our fight against COVID-19, saving countless lives in the UK and around the world.

“I’m extremely proud of our world-leading researchers and scientists who are responsible for developing some of the most effective vaccines and treatments during the pandemic and the NHS for the incredible roll out.

“The UK’s vaccination and booster programme is world leading but with the rapid spread of the Omicron variant, it is more important than ever that people come forward for their vaccines and booster to top up your immunity this winter and protect the progress we have made.”

The government invested early in Oxford University’s team, supporting their vaccine technology since 2016 and their COVID-19 jabs since March 2020 with more than £88 million to help research, develop and manufacture the vaccine.

The National Institute for Health Research’s (NIHR) helped recruit thousands of volunteers from across the UK for the phase 3 clinical trials and supported the researchers, which paved the way for approval by the independent Medicines and Healthcare products Regulatory Agency (MHRA).

Around 2.5 billion doses have been distributed at-cost to more than 170 countries. Almost two-thirds of these have gone to low and lower-middle-income countries, including more than 30 million doses donated by the UK through COVAX or bilaterally.

The UK will donate a further 20 million AstraZeneca doses to countries in need this year as part of the government’s commitment to donate 100 million doses overall.

Vaccines Minister Maggie Throup said: “The Oxford-AstraZeneca vaccine is a UK success story and demonstrates what can be achieved when researchers, scientists and the government work together.

“The at-cost vaccine has given billions of people around the world a way to fight back against this virus. Please get your vaccines and booster to protect yourself and your families this winter.”

The COVID-19 vaccination programme is the largest in British history and was established at unprecedented speed, with thousands of vaccine centres set up rapidly in England, meaning around 98% of people live within 10 miles of a vaccination clinic.

The government’s Vaccine Taskforce secured early access to almost 340 million doses of the most promising vaccine candidates in advance for the entire UK, Crown Dependencies and Overseas Territories, enabling a rapid deployment once approved by the medicines regulator.

NHS National Medical Director Professor Stephen Powis said: “Thanks to the extraordinary efforts of scientists and doctors, the Oxford/AstraZeneca vaccine was developed in just a matter of months instead of years, with NHS staff working tirelessly to roll the jabs out to millions across the country.

“The Oxford Astra Zeneca vaccine has played a crucial role in the biggest and most successful immunisation programme in NHS history, and I’d like to take this opportunity to remind people again that there are still hundreds of thousands of appointments available for first, second and booster jabs so please come forward and get jabbed.”

The UK led the world on vaccine research, providing results for three of the successful vaccine candidates through huge phase 3 trials for Oxford AstraZeneca, Janssen and Novavax vaccines. The Novavax trial is the largest ever double blind placebo controlled trial in the UK, recruiting 15,000 participants from 35 research sites in just over two months.

More than 133 million COVID-19 vaccinations have been administered in the UK in just over a year, including around 34 million boosters and third doses, securing vital protection against Omicron.

NASUWT: Action needed to protect UK schools from Omicron

Teaching union the NASUWT is calling on governments across the UK to take urgent measures to protect schools from the Omicron variant of Covid-19.

In England the Union has released a joint statement with the five other trade unions representing the majority of education staff prior to the return of schools and colleges for the spring term.

And in Scotland, Wales and Northern Ireland the NASUWT has called for urgent action from the Scottsh Government, the Welsh Government and the Northern Ireland Executive to protect schools now.

Dr Patrick Roach, NASUWT General Secretary said: “Teachers have been on the frontline throughout the pandemic to support pupils and students and provide them with the best education possible.

“However, the rising number of cases of the Omicron variant could cause significant disruption in the next academic term with many teachers being forced to self-isolate.

“We must see immediate action to ensure that schools can continue to operate safely and provide high quality education.”

The statement below is from NASUWT, ASCL, GMB, NAHT, NEU and UNISON:

“There has been much speculation about the possibility of more disruption to education over the next academic term as a result of the Omicron variant of Covid-19.

“As trade unions representing the vast majority of education staff, we wish to emphasise that teachers, leaders and support staff desperately want to be able to conduct face-to-face teaching for all children and young people on a consistent basis and without further interruption caused by the pandemic.

“Education staff have moved heaven and earth to support pupils and students throughout the course of the crisis and they remain committed to providing the best possible support for all children and young people.

“They are acutely conscious that this is essential particularly in supporting disadvantaged and vulnerable children and young people who have often been most badly affected by the pandemic both educationally and in terms of their wellbeing.

“But last term education staff were more likely than other workers to test positive and therefore to have to self-isolate, inevitably leading to disruption of education.

“Schools and colleges cannot on their own reduce the threat posed by the virus and they need from the Westminster government more than rhetoric about the importance of education.

“We need the minimum amount of educational disruption this term in order to avoid a third successive year where GCSEs, A-levels and other exams have to be cancelled, and thereby removing the uncertainty and additional workload for students and teachers.

“It is essential therefore that the government takes immediate and urgent steps to mitigate the risk of Covid transmission and that it provides more support to minimise disruption in schools and colleges by such steps as:

Providing government-funded air cleaning units to every school and college classroom that needs these devices. While we welcome the provision of a small number of these units to special educational needs and alternative provision settings, the government’s decision to signpost all other schools and colleges to purchase this equipment from an ‘online marketplace’ is simply not good enough. We also question why the Westminster government takes such a different line on face coverings in secondary schools to Scotland and Wales when they use the same evidence.

Committing to providing schools with more resources in the event that on-site Covid testing is again required. Secondary schools have once again been left in the lurch at the beginning of the spring term by being asked to set up and staff testing stations with little support from the government.

Providing improved financial support to schools and colleges for the costs of supply staff to cover for Covid-related absence. The current government scheme contains so many complex conditions that it is inaccessible in many circumstances.

Making it clear that all schools or colleges due for an Ofsted inspection this term can request that the inspection is deferred, and that their request will be automatically granted. This will enable teachers and leaders to focus on the immediate and urgent task in hand – that of supporting their pupils and students – and remove the unnecessary pressure and distraction of unhelpful inspections at this time.

“As a new year begins, we urge the government to work more collaboratively and constructively with education workforce representatives to keep schools and colleges open. By working side by side, we can remove unnecessary burdens and find solutions with government in the interests of all children and young people.”

Omicron: Greater Glasgow to operate essential-only visiting

Due to the increasing challenges faced as a result of the new Omicron variant, and in order to protect the safety of our patients and staff, the difficult decision has been taken to operate essential-only visiting from Wednesday 5 January 2022 in our adult hospital wards.

This change will include maternity services meaning only one essential visitor will be permitted in all parts of the maternity pathway.

Jennifer Rodgers, Deputy Nurse Director at NHSGGC, said: “This has been one of the hardest decisions to take but it is essential to help protect our patients, visitors and staff. We recognise how difficult this is for patients and the people that matter most to them and we will keep this under close review so that restrictions are not in place any longer than is necessary.

“This decision has been reached in conjunction with senior infection control, public health, clinical and operational teams, and in the best interests of patient wellbeing.

Jennifer added: “Essential visiting arrangements will be applied flexibly and compassionately, and each patient’s needs considered on their own merits. Carers, those providing essential care or emotional support, or spiritual care are not considered to be visitors and will continue to be permitted to attend a patient in hospital.

“Essential visits will be supported wherever possible and include the following illustrative examples: 

A birth partner supporting a woman during hospital visits and throughout the maternity pathway
A person receiving end-of-life care – we expect this to be defined as flexibly and compassionately as possible, to support patients at the end of life spending meaningful time with their loved ones in their final days, weeks or months
To support someone with a mental health issue, or dementia, or a learning disability or autism, where not being present would cause the patient to be distressed
To accompany a child in hospital
In general situations when someone is receiving information about life-changing illness or treatments.
In these and other similar situations where support from another person is essential for advocacy and wellbeing, family support should be facilitated.

Evelyn Frame, Chief Midwife said: “We understand that support from birthing partners has a positive impact on a woman’s experience so making this decision has been very difficult but, as this variant seems to be more transmissible, our priority has to be keeping our women and staff as safe as possible.

“For our inpatient areas we encourage a person-centred, flexible visiting approach and within ante-natal and post-natal visiting continues but only the birthing partner will be allowed. No other visitors will be allowed including siblings. During labour and birth only one birthing partner will also be allowed to stay throughout the whole labour experience.

“In our outpatient areas – anyone coming for a scan, early pregnancy or day care, or perhaps an outpatient appointment with one of our physiotherapist, dietician, midwife or obstetrician there is no change and you can bring your birthing partner for the duration of your appointment.

“Anyone with questions about visiting arrangements should speak to their midwife.”

Angela O’Neil Deputy Nurse Director said: “we recognise how difficult it is for families being apart, especially when their loved one is unwell.

“Where possible ward staff will continue to support patients to maintain contact with those closest to them however due to the extreme pressures staff are under if may not be possible to give an exact time or day when a video call or telephone call can be guaranteed.

“We are sorry for any distress this may cause and of course, staff will always try to facilitate these calls where possible, however we ask for your understanding while we try to manage under very challenging circumstances. Further information on arranging a virtual visit can be found on the NHSGGC Webpages

“The successful ‘Give and Go Service’ available earlier in the pandemic will be remobilised for family to drop-off essential personal items for patients and to pick up laundry etc.

“The service will be available from Wednesday 5 January 2022, and thereafter Monday – Friday as follows:

Queen Elizabeth University Hospital (main atrium) – items should also be dropped off here for patients in the INS – available between 12pm – 4pm
Glasgow Royal Infirmary (medical block entrance) – available between 12pm – 5pm
Royal Alexandra Hospital (main hospital foyer) – available between 12pm – 5pm
Beatson West of Scotland Cancer Centre (main entrance), available between 8.30am – 3.30pm, and
Local arrangements will be in operation in all other sites.

“Please speak to ward staff who will advise of local arrangements for dropping off and collecting belongings. 

“Further information can be found on the Give and Go Webpage.

“It should be noted Current visiting arrangements will remain in place until Tuesday 4 January 2022. These are as follows:

Patients in shared accommodation such as nightingale type wards and 4 and 6 bedded bays will be able to have essential visits only
Patients in single room accommodation will be able to benefit from the support of one visitor. This visitor can change each day.  
Two visitors per day is recommended for patients in paediatrics, neonates and maternity wards. 
Mental Health, Addictions and Learning Disabilities staff will make a visiting plan with each patient based on their individual needs and circumstance, and the local risks that present in each ward.
In line with infection prevention and control practice, wards with current active infection cases are required to temporarily restrict visiting to essential visits only
As always, there may be some individual patients who are particularly vulnerable to the risks of infection. For these patients, visiting will remain at essential visits only.

“We would like to thank our patients and their loved ones in advance for their patience and support during this incredibly difficult and challenging time.”

Additional information can be found on the NHSGGC Visiting Webpages and on our social media channels.

Damehood for Dr. Jenny Harries

UKHSA Chief Executive, Dr Jenny Harries, has received the title of Dame Commander of the Order of the British Empire for her outstanding service to public health.

Jonathan Turner, Head of Scientific and Technical Services has been awarded an MBE with Professor Kevin Fenton, London Regional Director of Public Health, Office for Health Improvement and Disparities, awarded a CBE.

Dr Harries has worked tirelessly to keep the nation safe during the COVID-19 pandemic with a focus on providing advice and support to the most vulnerable people in the country. Throughout the pandemic, she has provided health advice to the public at critical times in her role as Deputy Chief Medical Officer.

Dr Harries is now the Chief Executive of the newly formed UK Health Security Agency which brings together Public Health England and NHS Test and Trace, including the Joint Biosecurity Centre, with a remit to plan and prepare for current and future threats to our health.

Dr Harries is uniquely placed to understand the national challenges the nation faces and the importance of working closely with local and regional colleagues to address them, particularly supporting the most vulnerable in our communities.

Prior to becoming Deputy Chief Medical Officer, Dr Harries was the Deputy Medical Director at Public Health England, where she played a leading role in the UK’s response to Ebola in West Africa. She also provided crucial expertise to the Zika epidemic response, helping provide scientific advice and input to early studies to provide reassurance to expectant mothers across the UK at a time of considerable concern.

She also led the successful responses to the detection of MERS in the UK and the first UK cases of Monkeypox, ensuring dangerous infectious diseases were swiftly contained.

Using knowledge from her previous role as PHE Director for the South of England, Dr Harries was instrumental in shaping both the national and local public health response to the Novichok attack in Salisbury. Her public health advice helped contain the risk to the public.

Dame Dr Jenny Harries said: “I am hugely honoured to receive this award. It is accepted on behalf of the countless brilliant and committed colleagues in clinical and scientific communities as well as those who provide such dedicated operational response through every health protection incident and emergency.

“It is they, who have inspired and supported me throughout my career and who continue to work tirelessly to make the UK a safer place, often largely out of sight of the public.

“In the response to COVID-19, and in so much else, the unprecedented speed and diligence of scientific endeavour has saved many thousands of lives and I hope that today’s award will encourage more people, especially women, to pursue careers in science and public service.”

Ian Peters, UKHSA Chair, said: Jenny has made an enormous contribution to protecting the country’s health during an outstanding career. She has repeatedly provided leadership in helping to resolve the most challenging health issues in the UK and overseas, providing expert advice and a reassuring voice during incredibly critical times.

“From the outset in the pandemic firstly as Deputy CMO, and since April as CEO of UKHSA she has combined her public health knowledge and her wide experience, with an integrity and calmness of approach which has led to the saving of many lives. Her honour is thoroughly deserved

Jonathan Turner, Head of Scientific and Technical Services, has worked as a Biomedical Scientist for over 30 years to develop patient-centred and health protection focused public health microbiology services in the South West and across the national network.

Jonathan Turner said: “I am thrilled and honoured to accept this award but do so on behalf of the team in Bristol and the wider diagnostic community. I recognise the efforts of all the team, the support staff, our administrators, warehouse staff, logisticians, and managers as well as our clinicians and scientists.

“I also need to recognise the volunteers that came to our aid, without whom we would not have been able to achieve this response.”

Professor Kevin Fenton, London Regional Director of Public Health, Office for Health Improvement and Disparities, has received a CBE for his 30 years of service and leadership across all domains of public health.

This includes a recognition of his work in improving health outcomes in complex public health programmes including HIV prevention, sexual and reproductive health, child obesity, mental health, health equity and social regeneration, and leading London’s public health response during COVID-19.

Professor Kevin Fenton said: “I am honoured and humbled to receive such a prestigious award alongside other outstanding individuals. As we enter the third year of the COVID-19 pandemic response I am continually inspired by the professionalism, resilience and contributions of so many amazing colleagues who work relentlessly to keep us all safe and well.

“I am accepting this award on behalf of all the incredible public health and NHS teams I am privileged to lead and work with in London and around the nation, who are committed to improving health, tackling health inequalities, building resilient communities and providing high quality health and care services to all.

“They exemplify the best of public health and should be proud of all they have achieved.”